Effect of Intravenous Fentanyl on Ticagrelor Absorption and Platelet Inhibition Among Patients Undergoing Percutaneous Coronary Intervention Journal Articles

Overview
Research
Identity
Additional Document Info
View All

authors

McEvoy, John W
Ibrahim, Khalil
Kickler, Thomas S
Clarke, William A
Hasan, Rani K
Czarny, Matthew J
Keramati, Ali R
Goli, Rakesh R
Gratton, Travis P
Brinker, Jeffrey A
Chacko, Matthews
Hwang, Chao-Wei
Johnston, Peter V
Miller, Julie M
Trost, Jeffrey C
Herzog, William R
Blumenthal, Roger S
Thiemann, David R
Resar, Jon R
Schulman, Sam

status

published

publication date

January 16, 2018

has subject area

1102 Cardiorespiratory Medicine and Haematology (FoR)
1103 Clinical Sciences (FoR)
1117 Public Health and Health Services (FoR)
Administration, Intravenous (MeSH)
Administration, Oral (MeSH)
Analgesics, Opioid (MeSH)
Baltimore (MeSH)
Blood Platelets (MeSH)
Cardiovascular System & Hematology (Science Metrix)
Drug Interactions (MeSH)
Drug Monitoring (MeSH)
Female (MeSH)
Fentanyl (MeSH)
Gastrointestinal Absorption (MeSH)
Humans (MeSH)
Male (MeSH)
Middle Aged (MeSH)
Percutaneous Coronary Intervention (MeSH)
Platelet Aggregation (MeSH)
Platelet Aggregation Inhibitors (MeSH)
Platelet Function Tests (MeSH)
Purinergic P2Y Receptor Antagonists (MeSH)
Receptors, Purinergic P2Y12 (MeSH)
Risk Assessment (MeSH)
Ticagrelor (MeSH)
Time Factors (MeSH)
Treatment Outcome (MeSH)

published in

Circulation Journal